Brief: Gilead Will Pay Cymabay Therapeutics Termination Fee Of $151.6 Mln If Agreement Is Terminated
12/02/2024 13:44
Feb 12 (Reuters) - Gilead Sciences Inc GILD.O :
* GILEAD - UNDER TERMINATION OF AGREEMENT UNDER SOME
CIRCUMSTANCES
COMPANY WILL PAY CYMABAY THERAPEUTICS A TERMINATION FEE OF
$151.6 MILLION
Source text for Eikon: ID:n0000950103-24-002027
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap